Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia (NCT06580340) | Clinical Trial Compass
CompletedNot Applicable
Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia
Italy14 participantsStarted 2024-09-10
Plain-language summary
The present study aims to evaluate the modification of functional capacity induced by an adapted physical activity program in subjects with haemophilia.
The exercise program used aims to improve joint mobility, muscle strength, static and dynamic balance, motor coordination.
The program is structured in 1 hour sessions of 2 days/week and lasts 6 months.
The primary endpoint is the change in functional capacity calculated as the difference between the baseline assessment and the 3 and 6 month assessment of the 6 Minutes Walking Test measured with the G-Walk (BTS Bioengineering S.p.A).
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of hemophilia A or B;
* Signature of informed consent;
* Availability of a medical certificate for non-competitive activities
Exclusion Criteria:
* Active bleeding
* Severe joint deformities that prevent exercise
* Insufficiency of communicative and/or sensory functions so severe that it is impossible to understand or carry out the trainer's instructions (dementia, aphasia, blindness, deafness)
* Heart failure (NYHA class \> 2)
* Unstable angina
* Lung disease requiring oxygen therapy
* Symptomatic peripheral arterial disease
* Myocardial infarction or hospitalization within the previous 6 months
* Symptomatic orthostatic hypotension
* Hypertension in poor pharmacological control (diastolic\> 95 mmHg, systolic\> 160 mmHg)
* Significant neurological conditions that impair motor or cognitive function
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.